Serum Natriuretic Peptide testing as part of the heart failure diagnostic pathway Candy Jeffries National Improvement Lead for Heart Failure.

Slides:



Advertisements
Similar presentations
Referral Management & Choice Tower Thistle, London 13th May 2004.
Advertisements

Implementing NICE guidance
New Atrial Fibrillation/Flutter Pathway and GRASP Tool
Delivering Evidence Based Heart Failure Care Jane Dudley Heart Failure Specialist Nurse.
1 Developments and progress Dr Martin Freeman GP Clinical Lead for Dementia Services.
Sophie Whyte 1, Simon Dixon 1,Rita Faria 2, Simon Walker 2, Mark Sculpher 2, Stephen Palmer 2 1 ScHARR, University of Sheffield, Sheffield, UK; 2 CHE,
28th March 2013 Debbie Newton Chief Operating & Finance Officer
Practice based commissioning in Sutton and Merton PCT George Burns Practice Based Commissioning Development Manager
SCREENING FOR DISEASE Nigel Paneth. THREE KEY MEASURES OF VALIDITY 1.SENSITIVITY 2.SPECIFICITY 3.PREDICTIVE VALUE.
Copyright 2011 Right Care Using “Deep Dive” Insights packs in Northern and Yorkshire CCGs Sue Baughan Associate Director, Knowledge and Intelligence Team.
Eclipse A new era in medicines management. What is The Purpose of Medicines Management? – Educating Prescribers on Optimal Prescribing. – Improving Cost-effectiveness.
1 Key points – Heart Failure within Bradford 2011.
What type of information do service providers/ commissioners need? – good quality evidence to underpin service delivery/commissioning Screening Matched.
Dorset Improving Diagnosis of Heart Failure Implementation of BNP Measuring in General Practice Ist Project Steering Group 13 th Sept 2011.
Diagnosing Heart Failure Sanjay Kumar Lead Consultant Cardiologist Grace Williams Lead Heart Failure Specialist Nurse Croydon Health Services NHS Trust.
Breast Screening. NHS Breast Screening Programme Introduced in 1988 Invites women from age group for screening every 3 yrs. Age extension roll-out.
Background The 2 week wait referral system was designed to expedite the referral of patients, suspected to have cancer, from Primary to Secondary care.
Introducing NICE... Gateshead Council Gillian Mathews Implementation consultant - north.
Achieving improved cancer outcomes- a pathway approach, engaging primary care and partners Kathy Elliott Programme Director – NHS Improving Quality (Delivery.
St Albans and Harpenden PCT Heart Failure Service Dr Kate Mackay Director of Public Health.
Commissioning for Value Tool Bryn Shorney Analytical Services.
JONATHAN MANT, MD; ABDALLAH AL-MOHAMMAD, MD; SHARON SWAIN, BA, PHD; AND PHILIPPE LARAMEE,DC,MSC, FOR THE GUIDELINE DEVELOPMENT GROUP CHRIS FONTIMAYOR MS-III.
Heart Failure: From Failure to Success
How can new diagnostic methods contribute in healthcare? What are doctors looking for? Better support in their clinical decision makings, which includes:
West London Mental Health NHS Trust CQC Action Plan Response to Recommendations Nigel McCorkell - Chairman Peter Cubbon – Chief Executive Ian Kent – Deputy.
NICE quality standard for COPD Craig Grime Technical Analyst Quality Standards NICE
A model of service delivery and best use of Occupational Therapy staff within a community falls prevention service. F.Neil 1, M.Anderson 2, D.A. Skelton.
Journal Club Influence of Glycosylation on Diagnostic and Prognostic Accuracy of N-Terminal Pro–B-type Natriuretic Peptide in Acute Dyspnea: Data from.
Carpal Tunnel Syndrome A New Care Pathway. Format Introduction (5mins) SL Current Rheumatology issues (15mins) AY Current Orthopaedic Issues (10mins)
Respiratory Benchmarking Packs Yorkshire and the Humber September 2010.
Challenges Objectives CCG Led Initiatives Vision ‘How’ Outcome Aspirations Better integrated health and social care Improve the health and wellbeing of.
Hypertension: Blood Pressure Measurement and the new NICE guideline Prof Richard McManus BHS Annual Meeting Cambridge 2011 NICE clinical guideline 127.
BACR Standards: A Useful Tool? Jennifer George / Michelle Bull SWL Cardiac and Stroke Network.
WestawayGillis Innovators in Healthcare Solutions Development of a Business case in the NHS Mr Kim Sergeant Managing Director.
Developing Quality Indicators & Dashboards for Dementia Adam Cook South East Coast Quality Observatory.
Chronic Heart Failure Clinical case scenarios for primary care Educational Resource Implementing NICE guidance August 2010 NICE clinical guideline 108.
Chronic Heart Failure – An Update T P Chua Royal Surrey County Hospital, Guildford St George’s Hospital, London.
Heart Failure: a community-based diagnostic clinic & service
HOPE: Heart Outcomes Prevention Evaluation study Purpose To evaluate whether the long-acting ACE inhibitor ramipril and/or vitamin E reduce the incidence.
Cancer Mortality Target Measuring and Monitoring at a National Level Jennifer Benjamin, Department of Health Kathy Elliott, National Cancer Action Team.
REVIEW OF MATERNITY SERVICES TOPIC GROUP 4 th November 2009 FINANCE.
Board Report - Performance September 2008 Produced by Business Intelligence (Performance)
DIFFICULT DECISIONS IN HEALTH CARE Presentation to OJHOSC Dr Ljuba Stirzaker Oxfordshire Primary Care Trust 13 March 2008 ITEM JHO8(a) JHO3.MAR1308R03.ppt.
Copyright 2011 Right Care The Right Care Programme – Robust Decision Making Business Case Impact Assessments Commissioning for Value.
National Cancer Survivorship Initiative 2010 Update.
Framework for managing long term conditions The Plymouth PCT commissioning approach.
18 Week Pathway Discussion about potential IM&T issues.
Using data and intelligence to change ways of working Juliet Ashton Sapphire Nurse Consultant – Epilepsy Commissioning.
Intelligent Targets for Depression Dr Adrian Jones, ACOS Dr Alys Cole King, Consultant Liaison Psychiatrist Dr Teresa Ching, Consultant Respiratory Physician.
How to make evidence based practice happen - Identifying the local priorities Dr David Walker NHS Improvement National Clinical Lead for Heart Failure.
NTproBNP for the Exclusion of Heart Failure Richard Blakey.
Creating incentives for better quality: Lessons from the English NHS Jennifer Field, Associate Director National Institute for Health and Clinical Excellence.
South West Hepatitis C Needs Assessment Dr Maya Gobin Health Protection Services (South West)
© 2010 Jones and Bartlett Publishers, LLC. Chapter 12 Clinical Epidemiology.
1 Improving cardiology referrals from primary to secondary care INTERIM PROJECT REPORT - July 2010 Armon Daniels, Lead GP Mags Moss, Cardiac Specialist.
ResultsIntroduction Atrial Fibrillation (AF) affects 1.2% 1 of the population and 10% of those over the age of 75 2 It is the commonest arrhythmia in primary.
Methods Three questionnaires were designed with reference to national guidelines and the PCRMP’s recommendations. These questionnaires were sent to PCTs,
HF diagnosis: audit of NTproBNP uptake and outcomes across Sheffield An update on diagnosis and management of HF Dr Abdallah Al-Mohammad, MD, FRCP(Edin),
Scenario simulation – how computer modelling software could help you Candy Jeffries National Improvement Lead for Heart Failure.
Lothian Heart Failure Diagnostic Pathway
Chronic heart failure By Vishal Patel GPVTS1.
Fracture Liaison Service Database
Catriona Clark and Clare MacRae
HOPE: Heart Outcomes Prevention Evaluation study
Principal recommendations
Managing HF in Primary Care
Lothian Heart Failure Diagnostic Pathway
Catriona Clark and Clare MacRae
Managing HF in Primary Care
Presentation transcript:

Serum Natriuretic Peptide testing as part of the heart failure diagnostic pathway Candy Jeffries National Improvement Lead for Heart Failure

Heart Failure Diagnosis isn’t easy…. Heart failure out patient appointments cost the NHS £51m per year and £37m per year on diagnostic investigations alone 70% of patients referred for investigation for heart failure do not have heart failure 35% do not have a cardiac cause for their symptoms

NICE Chronic Heart Failure Guidelines August 2010 update Patients presenting with symptoms of heart failure and a history of previous MI should have an echo and be assessed by a specialist within 2 weeks. If no history of MI, measure Serum NP. If SNP levels raised( BNP, NTproBNP) should have an echo and be assessed by a specialist within 6 weeks If SNP levels high (>400 or >2000) should have an echo and be assessed by a specialist within 2 weeks Where echo shows no clear abnormality in a patient with previous MI, consider measuring SNP levels as they may indicate HF with preserved ejection fraction or other diagnosis SNP should also be considered for monitoring patients after admission or with problematic up-titration

The Evidence for Serum NP SNP levels are a clear indicator that the heart is being stretched and are 98% accurate as a negative predictor for heart failure. A large number of areas have audited services before and after introduction of Serum NP from Plymouth to E Yorks and Watford to Blackpool and shown improvement in clinical effectiveness, patient experience and cost savings.

Bedford General Hospital Referrals % Echos positive

Watford General Hospital

WGH % Echo positive

Hemel Hempstead GH

Savings Average saving over WH PCT was £3000 per PBC group per 6 months after BNP introduced Bedford Town PBC (with direct access echo) saved £5000 in 6 months E&N Herts PCT showed a total saving of £ in three months

Other trials Blackpool and Fylde reduced referrals to the heart failure direct access echo clinic by 38% Plymouth reduced theirs by 30% E Yorks modelled savings of between £70,000 and £110,000 per year using Scenario Generator and actual results against predicted were within the expected range for the first 7 months of 2010.

Comparative cost of Serum NP tests Serum NP tests vary from £15 - £25 per test 1 DA echo = BNP tests 1 OPA = tests 1 admission = tests

Lancs and Cumbria Computer simulation of the diagnostic pathway before and after the proposed introduction of Serum NP testing across the 6 PCTs Modelling showed annual cost savings of £100,000 per PCT where there was direct access echo, and £167,000 where the only option was referral into secondary care.

What is Scenario Generator? Computer simulation software designed specifically for use within the NHS by Simul8 and the Institute for Innovation and Improvement. Models how services of whole healthcare system could support care pathways Tests/compares responses to change in population, health, technology, practice and models of care Shows impact of throughput, cost and staffing Helps commissioners to find the most cost effective pathway

Limitations of Using Simulations Won’t tell you the answer, but help ask better questions Only as good as data put in, but help make sense of that data All models are wrong, but some are useful

As-Is Pathway

To-be Pathway

Data for modelling- yours or mine? Your pathway – open access echo? Out patient referral? Proportions? Population – or use national figures for your area- PCT or Consortia. Incidence – Usually use 0.13% but can alter if you know different. Referral rate, nationally around 0.4%- but can use your own figures. Costs: OPA £210, echo £90, SNP £20 are usual, but any or all can be changed. Usually model if SNP introduced exactly as now, if NICE guidelines are followed, and if SNP use is 25% higher than current referral rates

Heart Failure Model Year 1 Step Cost Year 2 Step Cost Year 3 Step Cost Year 4 Step Cost Year 5 Step Cost As Is Model£278,327£288,172£295,195£304,966£312,811 BNP Model - scenario 1 (stable/unstable ratio 90:10)£150,878£153,508£158,214£163,596£168,680 BNP Model - scenario 2 (stable/unstable ratio 80:20)£171,024£176,251£180,317£186,763£190,481 BNP Model - scenario 3 (stable/unstable ratio 70:30)£192,138£196,539£202,772£209,890£215,040 Savings Potential Scenario 1 - Full Year-£127,449-£134,664 - £136,981-£141,371-£144,131 Savings Potential Scenario 2 - Full Year-£107,302-£111,920 - £114,878-£118,204-£122,330 Savings Potential Scenario 3 - Full Year-£86,189-£91,633-£92,423-£95,076-£97,772

What is NHS Improvement offering Comprehensive cost modelling of the before and after SNP introduction pathways using Scenario Generator The chance for PCTs to see the effect of varying the pathway on costs by simulation a variety of pathways Worst and best case scenario simulations

In Conclusion Serum NP testing: Saves a small amount of money Improves clinical effectiveness Improves the patients experience NHS Improvement is offering computer simulation to help your business case. Can we help you?